Metagenomi (MGX) Earnings Date & Reports

Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

MGX is expected to report earnings to rise 5.88% to -72 cents per share on August 13

Q2'25

Est.

$-0.72

Q1'25

Beat

by $0.07

Q4'24

Beat

by $0.40

Q3'24

Beat

by $0.24

Q2'24

Beat

by $0.41

The last earnings report on May 14 showed earnings per share of -68 cents, beating the estimate of -75 cents. With 3.62M shares outstanding, the current market capitalization sits at 55.70M.

View a ticker or compare two or three

Compare

MGX